dr. govindan on the future of egfr-mutant nsclc
Published 7 years ago • 240 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
37:44
deciphering the data in egfr - mutant nsclc
-
0:47
the future of amivantamab and lazertinib in egfr-mutant nsclc
-
19:32
panel dicussion | dr krupa shankar | egfr mutant nsclc recent udates
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
0:59
dr. west on emerging changes in the field of egfr-mutant nsclc
-
3:37
living with alk positive lung cancer - patients testimonial
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
59:37
refining biomarker testing and targeted treatment of nsclc with egfr mutations
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
1:04
molecular testing in egfr mutant driven nsclc
-
20:38
future research and treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
21:35
long term management of egfr-mutant nsclc -tsao
-
57:03
panel discussion | dr krupa shankar | egfr mutant nsclc 1st line long term outcomes
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
28:32
dr. shivshankara swamy | slection of 1st line tki for egfr mutant nsclc
-
20:35
tki-resistant egfr-mutant nsclc
-
1:57
dr. piotrowska on treatment for egfr-mutant nsclc
-
1:35
dr. janjigian discusses afatinib and cetuximab for patients with egfr-mutant lung cancer
-
1:37
dr. konduri on treatment options for patients with egfr-mutant nsclc
-
1:47
dr. west on fda approval of afatinib in nsclc with rare egfr mutations
-
1:31
dr. gold on the future of osimertinib in lung cancer
-
1:21
the future of treatment for egfr-positive lung cancer